Latest Stock Split Details
Key information about Celltrion Pharm Inc's most recent stock split
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 1.05 times more shares (a 21:20 ratio)
- The price per share is reduced proportionally
Historical Stock Splits
A comprehensive history of Celltrion Pharm Inc's stock splits
Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
---|---|---|---|---|
2023-12-27 | 21:20 | No | $93450.00 | $89000.00 |
2022-12-28 | 21:20 | No | $74529.00 | $70980.00 |
2021-12-29 | 103:100 | No | $143877.35 | $139686.75 |
2020-12-29 | 51:50 | No | $289687.45 | $284007.31 |
2019-12-27 | 21:20 | No | $49681.80 | $47316.00 |
2017-12-27 | 51:50 | No | $73250.04 | $71813.76 |
2016-12-28 | 21:20 | No | $29006.39 | $27625.13 |
2015-12-29 | 103:100 | No | $20997.42 | $20385.84 |
2014-12-29 | 21:20 | No | $11152.56 | $10621.49 |
About Celltrion Pharm Inc
Company overview and industry information
Celltrion Pharm Inc (068760.KS) operates in the Drug Manufacturers - Specialty & Generic industry. The recent 21-for-20 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.